The purpose of writing this review on floating drug delivery systems (FDDS) was to compile the recent literature with special focus on the principal mechanism of floatation to achieve gastric retention . This can be achieved by use of various polymeric substances including natural polymers. These polymers are inexpensive, safe and available in a variety of structures with versatile characteristics. Large number of derivatizable groups, wide range of molecular weights, varying chemical composition gel forming nature of these polymers also provide an exciting opportunities in the fascinating arena of applied polymer science and drug delivery technology. All these characteristics make them suitable candidate for design and fabrication of novel gastroretentive drug delivery systems. Various natural polymers have been investigated worldwide by scientific community for their potential as floating drug delivery systems. The present article highlights various recent efforts and advanced approaches exploiting several natural polymers in this technology. DOI: http://dx.doi.org/10.3329/ijpls.v2i4.17116 International Journal of Pharmaceutical and Life Sciences Volume 2, Issue 4: October 2013; 165-178
7 September 2023 in International Journal of Applied Pharmaceutics
Micro-and nanorobotics is a new field of research that emerged from the fusion of micro/nanotechnology and robotics and has since acquired enormous importance. The advantages of micro-and nanorobots include their small dimension, lightweight, high flexibility, and high sensitivity. Micro-and nanorobots have sparked the scientific community's interest in research and opened up a broad variety of application areas, including medication delivery and disease diagnostics, due to their differences from macroscopic robots. Over the past 30 y, research on micro-and nanorobots has made major strides. This manuscript provides a detailed explanation of the development of these robots. Then, each of the primary robot components including their actuation, design, production, and control is discussed separately. Additionally, potential challenges in developing such robots are explored from the perspectives of intelligence and sensing, therapeutic applications, materials, and performance.
4 February 2025 in Indian Journal of Pharmaceutical Education and Research
Background Ocular drug delivery is hindered by a number of reasons, including nasolacrimal drainage, tear turnover and eye blinking. One of the important factors is rapid removal of drug from the eye. The fast elimination rate of drug leads to the loss of drug from the conventional dosage form like eye drop. So, to avoid this problem a novel formulation was designed in which drug will entrap in micro sponges and the micro sponges will be laden into gel. Aim The basic purpose of the study is to formulate atenolol loaded micro sponge gel for the treatment of glaucoma. The microsponges were laden into a gel base to enhance the dwelling time of formulations in eye. Materials and Methods Oil in oil emulsion diffusion method is used for formulating the microsponges by using polymers like Eudragit RS-100 and Eudragit RL-100. The microsponges were subjected to different analytical tools like particle size analysis, surface topography, drug entrapment efficiency, drug loading, pH determination, viscosity, in vitro release study and evaluated. The formulation was then laden in to the gel. The gel was then characterized for pH, viscosity and drug release study. Here, we have described a novel formulation of microsponges loaded gel of Atenolol for glaucoma with the complete characterization and in vitro release study. Results The particle size of microsponges was found to be in the range of 7.5±0.65 to 9.2±0.5μm. The entrapment efficiencies varied from 70.12% to 80.22%. The percentage yield of the microsponges were found in the range of 75.12 to 85%. The cumulative percentage drug release varies from 60.12% to 79.32%. The microsponge loaded gel has pH in the range of 6.94±0.78 to 7.39±0.65. The viscosity of the different formulation was 220 to 287 Pa.s. Conclusion Microsponges loaded gel of Atenolol for glaucoma with the complete characterization and in vitro release was studied. From the in vitro studies it can be revealed that the microsponge loaded gel may be exploited for future applications for management of glaucoma
The present study was an attempt to develop galactosylated albumin nanoparticles of Simvastatin for treatment of hypercholesterolemia. By developing the galactosylated nanoparticulated delivery, the required action of the drug at the target site at the liver can be provided. The advantage of targeting helps to reduce the systemic side effects that may occur due to the distribution of the drug to the other organs and thus helps in maintaining the required concentration of drug at the desired site. The galacotsylated albumin nanoparticles were prepared for the selective delivery of a Simvastatin to the 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) the rate-limiting enzyme in the pathway of cholesterol biosynthesis that is particularly presents on hepatocytes. The asialoglycoprotein receptor (ASGP-R) which is particularly presents on mammalian hepatocytes can be utilize for active targeting by using its natural and synthetic ligands. By utilizing this receptors can provides a unique means for the development of liver-specific carriers, such as liposomes, recombinant lipoproteins, and polymers for drug or gene delivery to the liver, especially to hepatocytes. These receptors recognize the ligands with terminal galactose or N-acetylgalactosamine residues, and endocytose the ligands for an intracellular degradation process. The albumin nanoparticles (NPs) were prepared by using desolvation method and efficiently conjugated with galactose. Various parameters such as particle size, zeta potential, percentage entrapment efficiency and drug loading efficiency, percentage yield, in-vitro drug release were determined. The size of nanoparticles (both plain and coated NPs) was 200 and 250 nm. The zeta potential of plain nanoparticles was -3.61 and that of galactose-coated nanoparticles was 64.1. The maximum drug content was in between 79.98% to 79.8 % respectively in plain, and galactose coated nanoparticles while the maximum entrapment efficiency was 70.10% and 71.03% in plain and coated nanoparticles. It was found that coating of nanoparticles increases the size of nanoparticles.
The review article is about the present trends and approaches used in the expansion of ocular drug release systems. The article begins with a concise sketch of the common anatomy of eye. Further, the approaches used in the development of ocular formulations are discussed. Approaches such as mucoadhesion, in-situ gels, colloidal carriers like nanoparticles, liposomes, niosomes, microemulsions, and microparticles are broadly reviewed. The challenges in ocular drug delivery are due to exceptional a